US stock · US markets · public data

DGX

Quest Diagnostics Inc · Healthcare

Reference price$233.56Updated according to the public source
P/E24.79
P/B3.42
ROE14.60%
DY 12M1.42%
Net margin—
Net debt/equity—
Market capUS$ 25.8 B
Volume (shares)392,282
SectorHealthcare
Overview

About DGX

Demonstrações públicas consolidadas + SEC Company Facts

Quest Diagnostics Inc (DGX) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
09/23
12/23
03/24
06/24
09/24
12/24
03/25
06/25
09/25
12/25
03/26
06/26
Income in shown records$9.34
DY 12M1.42%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$0.86
Period ending 2026-03-31Dividendo declarado$0.86
Period ending 2025-12-31Dividendo declarado$0.80
Period ending 2025-09-30Dividendo declarado$0.80
Period ending 2025-06-30Dividendo declarado$0.80
Period ending 2025-03-31Dividendo declarado$0.80

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$9,252,000,000.00$9,872,000,000.00$11,035,000,000.00—
Gross Profit————
Operating Income$1,262,000,000.00$1,346,000,000.00$1,556,000,000.00—
Net Income$854,000,000.00$871,000,000.00$992,000,000.00—
EPS Diluted$7.49 / share$7.69 / share$8.75 / share—

Balance sheet

Account2023202420252026
Total Assets$14,022,000,000.00$16,153,000,000.00$16,225,000,000.00—
Total Equity$6,342,000,000.00$6,813,000,000.00$7,206,000,000.00—
Long-term Debt$4,713,000,000.00$6,217,000,000.00$5,671,000,000.00—
Current Debt$303,000,000.00$602,000,000.00$504,000,000.00—
Shares Outstanding111,323,003 shares110,707,293 shares110,978,069 shares109,866,320 shares
Cash & Investments$686,000,000.00$549,000,000.00$420,000,000.00—
Dívida Líquida$4,330,000,000.00$6,270,000,000.00$5,755,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$1,272,000,000.00$1,334,000,000.00$1,886,000,000.00—
Capital Expenditures$408,000,000.00$425,000,000.00$527,000,000.00—
Dividends Paid$314,000,000.00$331,000,000.00$353,000,000.00—
Free Cash Flow$864,000,000.00$909,000,000.00$1,359,000,000.00—
FAQ

Frequently asked questions

What is the price of DGX?

The reference price available for DGX is $233.56.

What is the P/E of DGX?

The P/E ratio of DGX is 24.79. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of DGX?

The P/B of DGX is 3.42. This compares price with reported book value per share.

What is the ROE of DGX?

The ROE (Return on Equity) of DGX is 14.60%. This relates the reported net result to shareholders' equity.

What is the dividend yield of DGX?

The dividend yield of DGX is 1.42%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of DGX?

The market capitalization of DGX is US$ 25.8 B.

What sector is DGX in?

DGX operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.